Inlyta axitinib: Preliminary Phase Ib data

Preliminary data from 52 patients with previously untreated advanced RCC in the open-label, U.S. Phase Ib A4061079 trial showed that twice-daily oral Inlyta plus IV Keytruda pembrolizumab every 3 wee...